SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008564
Filing Date
2023-05-08
Accepted
2023-05-08 17:05:51
Documents
71
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eqrx-20230331x10q.htm   iXBRL 10-Q 1520831
2 EX-31.1 eqrx-20230331xex31d1.htm EX-31.1 18566
3 EX-32.1 eqrx-20230331xex32d1.htm EX-32.1 9592
  Complete submission text file 0001558370-23-008564.txt   7337270

Data Files

Seq Description Document Type Size
4 EX-101.SCH eqrx-20230331.xsd EX-101.SCH 48170
5 EX-101.CAL eqrx-20230331_cal.xml EX-101.CAL 47722
6 EX-101.DEF eqrx-20230331_def.xml EX-101.DEF 228910
7 EX-101.LAB eqrx-20230331_lab.xml EX-101.LAB 446206
8 EX-101.PRE eqrx-20230331_pre.xml EX-101.PRE 382757
65 EXTRACTED XBRL INSTANCE DOCUMENT eqrx-20230331x10q_htm.xml XML 1425799
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 (617) 315-2255
EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40312 | Film No.: 23898789
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences